Delivery Order SPE2DB20D3303-SPE2DB23FA0TT
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the pharmaceutical product WEGOVY 2.4 MG/0.75 ML PEN 0.75ML. The delivery order, valued at $1,097.08, has a completion date of February 21, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA with a potential value of $999,999,999.00 and a performance period through...
- The U.S. government's Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp a delivery order contract worth $12,850.04 for the pharmaceutical product WEGOVY 0.25 MG/0.5 ML PEN 0.5ML. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. Under this IDC, Amerisourcebergen provides a comprehensive range of pharmaceutical products and medical supplies to support...
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract, valued at $6,533.36, to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of the prescription drug WEGOVY 2.4 MG/0.75 ML PEN 0.75ML. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and Amerisourcebergen, valued up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary vehicle for Amerisourcebergen to provide a...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract worth $1,097.08 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of the pharmaceutical product WEGOVY 1 MG/0.5 ML PEN 0.5ML. The contract has a completion date of March 1, 2024. AmerisourceBergen Drug Corp is the prime contractor on this contract, which does not have a set-aside designation. The contract is associated with a larger indefinite delivery contract...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $1,239.64 order is for the pharmaceutical product WEGOVY 1 MG/0.5 ML PEN 0.5ML, with a completion date of February 21, 2024. Amerisourcebergen Drug Corp is the prime contractor on a $999,999,999.00 indefinite delivery contract (IDC) with DLA, through which it...
- The U.S. government awarded a delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, valued at $1,097.08. This firm fixed price order was issued by the Defense Logistics Agency (DLA) Troop Support Medical, supporting medical treatment programs and facilities operated by the Department of Defense. The order is for the pharmaceutical product WEGOVY 2.4 MG/0.75 ML PEN 0.75ML. Amerisourcebergen Drug Corp is the prime contractor on a larger indefinite delivery...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply the pharmaceutical product WEGOVY 1.7 MG/0.75 ML PEN 0.75ML. The $5,389.14 delivery order does not have a set-aside designation and is in support of DLA Troop Support Medical programs. Amerisourcebergen Drug Corp, operating out of its corporate headquarters in Conshohocken, Pennsylvania, is a long-standing prime contractor providing...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical services company Amerisourcebergen Corporation. The $2,994.80 contract is for the delivery of the prescription medication WEGOVY 1 MG/0.5 ML PEN 0.5ML. This delivery order is issued under an indefinite delivery contract (IDC) that Amerisourcebergen Drug Corp holds with DLA, which has a potential value of...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract to Amerisourcebergen Drug Corp for $3,291.24 to supply the pharmaceutical product WEGOVY 1.7 MG/0.75 ML PEN 0.75ML. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and Amerisourcebergen, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of medical commodities to support military treatment programs and...
- The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide WEGOVY 0.5 MG/0.5 ML PEN 0.5ML. The $3,470.17 delivery order has a performance period ending on February 13, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used. This award is part of a larger indefinite delivery contract (IDC) between Amerisourcebergen Drug Corp...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB23FA0TTDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,645.62 to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of the pharmaceutical product WEGOVY 0.5 MG/0.5 ML PEN 0.5ML. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. The IDC allows DLA to efficiently procure a comprehensive range of pharmaceutical products and medical supplies to support the Department of Defense's military treatment programs and facilities worldwide. Amerisourcebergen, a subsidiary of Cencora, Inc., is a major supplier of pharmaceutical products and medical supplies to the federal government, with a focus on serving the Department of Defense and Veterans Affairs healthcare systems. The delivery order does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 8/17/23 |